Nasus Pharma Announces Positive Clinical Results of Recent Phase 2 Study With FMXIN002 Intranasal Epinephrine
Rapid and higher epinephrine absorption- for potentially quicker rescue of patients in anaphylactic shock
Source: channel3000.com
Dalia Megiddo News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Dalia Megiddo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Dalia Megiddo Today - Breaking & Trending Today
Nasus Pharma Announces Publication Of Its Positive Clinical Results With FMXIN002 Intranasal Powder Epinephrine Spray In The Journal Of Allergy And Clinical Immunology In Practice
/PRNewswire/ -- Nasus Pharma Ltd a clinical-stage biopharmaceutical company focused on developing needle-free, powder-based Intranasal (PBI) product portfolio,...
Source: prnewswire.com
Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix®, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection
/PRNewswire/ -- Nasus Pharma a privately held clinical-stage biopharmaceutical company developing a powder-based intranasal (PBI) product portfolio to address...
Source: prnewswire.com
Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix®, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection
/PRNewswire/ -- Nasus Pharma a privately held clinical-stage biopharmaceutical company developing a powder-based intranasal (PBI) product portfolio to address...
Source: prnewswire.com
Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection
NP-003 study terminated early with high significance in reducing viral infection. TEL AVIV , Israel, Nov. 24, 2021 /PRNewswire/ -- Nasus Pharma a privately held clinical-stage biopharmaceutical
Source: finanznachrichten.de